Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Hsu Chang

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Personalized Medicine|January 21, 2023
Recognition of Postoperative Cystography Features by Artificial Intelligence to Predict Recovery from Postprostatectomy Urinary Incontinence: A Rapid and Easy Way to Predict Functional OutcomeI-Hung Shao, Hung-Cheng Kan, Hung-Yi Chen, et al.
Journal of Oncology|September 6, 2021
Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation TherapyYen-Chi Lin, Po-Hung Lin, I-Hung Shao, et al.
Journal of Advanced Nursing|August 4, 2020
Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: A quasi-experimental studyChing-Hui Chien, Hsiao-Jen Chung, Kuan-Lin Liu, et al.
Biomaterials|August 30, 2011
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapyMu-Yi Hua, Hung-Wei Yang, Hao-Li Liu, et al.
ACS Nano|January 18, 2012
Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapyHung-Wei Yang, Mu-Yi Hua, Hao-Li Liu, et al.
Oncotarget|October 21, 2017
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screeningCheng-Lung Hsu, Jai-Shin Liu, Ting-Wei Lin, et al.
Experimental and Therapeutic Medicine|September 29, 2021
Gain of TPPP as a predictor of progression in patients with bladder cancerYing-Hsu Chang, Po-Hung Lin, Chin-Chang Chen, et al.
Scientific Reports|August 30, 2024
Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancerI-Hung Shao, Fan-Ting Liao, Chun-Bi Chang, et al.
Therapeutics and Clinical Risk Management|December 27, 2024
Predicting Bleeding Related Events in Robotic-Assisted Partial Nephrectomy for Angiomyolipoma: Simplifying Risk Assessment with Tumor Diameter and Depth, A Retrospective StudyMing-Chien Chen, Ying-Hsu Chang, Ting-Wen Sheng, et al.
Tumori|April 13, 2021
Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomyShih-Huan Su, Ying-Hsu Chang, Liang-Kang Huang, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Personalized Medicine|January 21, 2023
Recognition of Postoperative Cystography Features by Artificial Intelligence to Predict Recovery from Postprostatectomy Urinary Incontinence: A Rapid and Easy Way to Predict Functional OutcomeI-Hung Shao, Hung-Cheng Kan, Hung-Yi Chen, et al.
Journal of Oncology|September 6, 2021
Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation TherapyYen-Chi Lin, Po-Hung Lin, I-Hung Shao, et al.
Journal of Advanced Nursing|August 4, 2020
Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: A quasi-experimental studyChing-Hui Chien, Hsiao-Jen Chung, Kuan-Lin Liu, et al.
Biomaterials|August 30, 2011
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapyMu-Yi Hua, Hung-Wei Yang, Hao-Li Liu, et al.
ACS Nano|January 18, 2012
Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapyHung-Wei Yang, Mu-Yi Hua, Hao-Li Liu, et al.
Oncotarget|October 21, 2017
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screeningCheng-Lung Hsu, Jai-Shin Liu, Ting-Wei Lin, et al.
Experimental and Therapeutic Medicine|September 29, 2021
Gain of TPPP as a predictor of progression in patients with bladder cancerYing-Hsu Chang, Po-Hung Lin, Chin-Chang Chen, et al.
Scientific Reports|August 30, 2024
Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancerI-Hung Shao, Fan-Ting Liao, Chun-Bi Chang, et al.
Therapeutics and Clinical Risk Management|December 27, 2024
Predicting Bleeding Related Events in Robotic-Assisted Partial Nephrectomy for Angiomyolipoma: Simplifying Risk Assessment with Tumor Diameter and Depth, A Retrospective StudyMing-Chien Chen, Ying-Hsu Chang, Ting-Wen Sheng, et al.
Tumori|April 13, 2021
Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomyShih-Huan Su, Ying-Hsu Chang, Liang-Kang Huang, et al.
Pageof 10